Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023

Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023

Report Details

Contract manufacturing for pharma - discover top companies' revenue prospects

How are pharma contract manufacturing organisations (CMOs) performing? Visiongain's new report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions.

Our study analyses 30 leading CMOs. There you discover how revenues from drug production services can increase.

That way you find information you need on established and emerging companies. Read on to scan those organisations and see what their future market could be worth.

Forecasts and other data to help you stay ahead

In our new study you find analytical profiles of 30 top companies, and analyses of the overall industry. You discover historical data, market shares, revenue forecasts, and growth rates. See, too, qualitative analysis, business outlooks and developments.

There you also gain 141 tables, 58 charts, and five interviews with the industry.

Our work lets you assess the most lucrative services in outsourced drug making. That way you can stay ahead in knowledge of the CMO industry and market:
• Finished dosage formulations (FDF) manufacturing
• Active pharmaceutical ingredients (API) production.

See now how you can benefit your research, analyses and decisions, also saving time. The following sections highlight what you find in our new investigation.

Company profiles - activities, results, competition, and prospects

Our report analyses 30 leading companies. The content of each profile differs, depending on the company. In general, though, a profile gives you the following information:
• Overview of the company's contract manufacturing services, including clients
• Analysis of recent financial performance - overall revenue and that for CMO services
• Assessment of developments - acquisitions, capacity expansions, new service offerings, and collaborations
• SWOT analysis of the company - strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2013 to 2023
• Forecasting of pharmaceutical contract manufacturing revenues to 2023, for 23 of the companies
• Transcript of an interview by visiongain, for five of the companies.

Discover there what participants achieve, do, and say, helping you stay ahead.

European contract manufacturing organisations

First, our study gives you discussions, financial analyses, and commercial outlooks for 15 European CMOs, including these:
• Lonza
• Evonik Degussa
• Royal DSM
• Boehringer Ingelheim Biopharmaceuticals
• Famar
• Fareva
• Vetter Pharma.

Discover what the future holds for those pharma service providers, including revenue outlooks to 2023.

Companies based in the US and Japan

Next, our report shows you developments and sales outlooks to 2023 for five other companies:
• Catalent Pharma Solutions
• Patheon
• AbbVie Contract Manufacturing
• Daito Pharmaceutical
• Pfizer CentreSource.

Our work shows you where sales growth can occur. Many opportunities remain, with high, expanding revenues possible from 2013. You see where prospects exist.

Developed-market API specialists

You also discover outlooks for four top producers of active pharma ingredients:
• Teva API
• Esteve Química
• Euticals
• Cambrex.

Our report shows you potentials of the industry. You see possibilities for advancing technology and raising business performance.

India and China - analysis of pharma manufacturing service providers

Our work also assesses six Indian and Chinese companies. There you discover activities and prospects of these firms:
• Dr. Reddy's Laboratories
• Aurobindo Pharma
• Divis Laboratories
• Shandong Xinhua Pharmaceutical
• Zhejiang Hisun Pharmaceutical
• Zhejiang Huahai Pha
Companies Listed

Abbott
AbbVie
AbbVie Contract Manufacturing
Abic (part of Teva)
Activa Capital
Aegerion Pharmaceuticals
Aenova
Aerofarm (part of Fareva)
Aesica Pharmaceuticals
Agence Nationale de sécurité du Médicament et des produits de santé (ANSM) [France]
Agência Nacional de Vigilância Sanitária (ANVISA) [Brazil]
Agennix
Ajinomoto OmniChem
AlgoNomics (part of Lonza)
Alliance Medical Products (part of Siegfried)
Almac Group
Alpharma
Amgen
Apexigen
Aptuit
Archimica (part of Euticals)
Arecor
Astellas Pharma
AstraZeneca
Athera Biotechnologies
Aurobindo Pharma
AuroSource (part of Aurobindo Pharma)
Avalanche Biotechnologies
Banner Pharmacaps (part of Patheon)
BaroFold
Barr-Pliva (part of Teva)
BASF
Bayer
BC Partners
Beijing Double-Crane Pharmaceutical (BDCP)
Bellwyck Packaging Solutions
Bend Research
Bentley Pharma (part of Teva)
Biogal
Bionomics
Blackstone Group
Boehringer Ingelheim
Boehringer Ingelheim Biopharmaceuticals
Bridgepoint
Bristol-Myers Squibb
Britest
Cambrex
Cardinal Health
Catalent (Shanghai) Clinical Trial Supplies Co
Catalent Pharma Solutions
Celladon
Celldex Therapeutics
CEVEC Pharmaceuticals
Chemo
Chemtrix
China National Pharmaceutical Group (Sinopharm)
Chirotech Technology (part of Dr. Reddy's Laboratories)
Cleveland BioLabs
Cobra Biologics Holding
CordenPharma (part of ICIG)
CPM ContractPharma (part of Aenova)
CTC Bio
Daiichi Sankyo
Daito Pharmaceutical
DecImmune Therapeutics
Delmas Perfusion
Delpharm
DiFUSION Technologies
Divis Laboratories
Dr. Reddy's Laboratories
DSM Sinochem Pharmaceuticals
Durham University
Eclipse Therapeutics (part of Bionomics)
Eindhoven University of Technology
Eisai
Eli Lilly
EmulTech
Enobia Pharma (now Alexion Pharmaceuticals)
Enzon Pharmaceuticals
Esteve
Esteve Química (part of Esteve)
Euro Vital Pharma (part of Aenova)
European Medicines Agency (EMA)
Euticals
Evonik Degussa (part of Evonik Industries)
Evonik Industries
Excella (part of Fareva)
Excelvision (part of Fareva)
Exelixis
Famar
Fareva
Farma Lepori (part of Angelini Group)
Farmaclair (part of Fareva)
Farmaprojects
Farmea (part of Fareva)
Food and Drug Administration (FDA) [US]
Frazier Healthcare
Fuyang Xinghai Investment
Genentech (part of Roche)
Générique Même Médicament (GEMME) [France]
Genzyme (part of Sanofi)
Gilead Sciences
GSK
Gyma Laboratories of America
Haupt Pharma
Health and Safety Executive (HSE) [UK]
Health Canada
Hisun-Pfizer Pharmaceuticals
Human Genome Sciences (part of GSK)
ICI (Imperial Chemical Industries)
Immune Pharmaceuticals
Indoco Remedies
Instituto de Angeli (part of Fareva)
Intellect Neurosciences
International Chemical Investors Group (ICIG)
Invita
Ipsen
Ivax API (part of Teva)
J&J
JK Pharmaceutical
Laboratoire Aguettant
Laboratoires Besins
Lanxess
Lonza
Marinopoulos Group
Medicines and Healthcare Products Regulatory Agency (MHRA) [UK]
Merck & Co.
Merck KGaA
Mesoblast
Molecular Partners
Mylan
National Institutes of Health (NIH) [US]
National Institutes of Health Center for Regenerative Medicine (NIH CRM) [US]
New Jersey Institute of Technology
Novartis
Novasep
OctoPlus (part of Dr. Reddy's Laboratories)
OmniChem (part of Ajinomoto OmniChem)
OncoMed Pharmaceuticals
Osiris Therapeutics
Otsuka Pharmaceutical
Pantec
Paranta Biosciences
Parexel
Patheon
Perrigo
PFC (now Teva PFC)
Pfizer
Pfizer CentreSource (part of Pfizer)
Pharmintraco
Piramal Pharma Solutions (part of Piramal Enterprises)
Plantex (part of Teva)
Poli Industria Chimica (part of Euticals)
Procaps
Prosintex Química
R5 Pharmaceuticals (part of Aesica Pharmaceuticals)